US 11235026
Methods and compositions for modulating PD1
granted A61KA61K35/17A61K38/00
Quick answer
US patent 11235026 (Methods and compositions for modulating PD1) held by Sangamo Therapeutics, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K35/17, A61K38/00, A61K38/1709, A61P